These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. How do you distinguish a malignant pelvic mass from a benign pelvic mass? Imaging, biomarkers, or none of the above. Moore RG; Bast RC J Clin Oncol; 2007 Sep; 25(27):4159-61. PubMed ID: 17698803 [No Abstract] [Full Text] [Related]
5. [Preoperative identification of malignancy among women with a pelvic mass. Evaluation of a risk index based on ultrasound findings. CA 125 in serum and menopausal status]. Hagen B; Tingulstad S; Onsrud M; Moen M; Kiserud T; Eik-Nes S; Halvorsen T; Nustad K Tidsskr Nor Laegeforen; 1995 Mar; 115(7):820-2. PubMed ID: 7701488 [TBL] [Abstract][Full Text] [Related]
6. Comparison of three risk of malignancy indices in evaluation of pelvic masses. Manjunath AP; Pratapkumar ; Sujatha K; Vani R Gynecol Oncol; 2001 May; 81(2):225-9. PubMed ID: 11330953 [TBL] [Abstract][Full Text] [Related]
7. Accuracy of tissue polypeptide specific antigen (TPS) in the diagnosis of ovarian malignancy. Padungsutt P; Thirapagawong C; Senapad S; Suphanit I Anticancer Res; 2000; 20(2B):1291-5. PubMed ID: 10810437 [TBL] [Abstract][Full Text] [Related]
9. [Role of echography in the diagnosis of pelvic masses. Apropos of 60 cases]. Boury-Heyler C; Bonan J; Nordman-Amar M Chirurgie; 1982 Jun; 108(6):509-12. PubMed ID: 7151523 [No Abstract] [Full Text] [Related]
10. Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter study. Schutter EM; Sohn C; Kristen P; Möbus V; Crombach G; Kaufmann M; Caffier H; Kreienberg R; Verstraeten AA; Kenemans P Gynecol Oncol; 1998 Apr; 69(1):56-63. PubMed ID: 9570999 [TBL] [Abstract][Full Text] [Related]
11. Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses. Chen X; Zhou H; Chen R; He J; Wang Y; Huang L; Sun L; Duan C; Luo X; Yan H Clin Chim Acta; 2015 Feb; 440():57-63. PubMed ID: 25447698 [TBL] [Abstract][Full Text] [Related]
12. A risk of malignancy index in preoperative diagnosis of ovarian cancer. Ma S; Shen K; Lang J Chin Med J (Engl); 2003 Mar; 116(3):396-9. PubMed ID: 12781045 [TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen in women with isolated pelvic masses. Clinical utility? Roman LD; Muderspach LI; Burnett AF; Morrow CP J Reprod Med; 1998 May; 43(5):403-7. PubMed ID: 9610461 [TBL] [Abstract][Full Text] [Related]
14. Prospective comparison of ultrasound and computed tomography in the evaluation of gynecologic pelvic masses. Walsh JW; Rosenfield AT; Jaffe CC; Schwartz PE; Simeone J; Dembner AG; Taylor KJ AJR Am J Roentgenol; 1978 Dec; 131(6):955-60. PubMed ID: 104597 [TBL] [Abstract][Full Text] [Related]
15. [Vaginal needle biopsy in large pelvic tumors for the purpose of histological evaluation. Preliminary study with a proposal for a new biopsy technic employing needles of 2 calibers]. Serup J Ugeskr Laeger; 1979 Feb; 141(6):355-7. PubMed ID: 419579 [No Abstract] [Full Text] [Related]
16. [Clinical significance of computed tomography (CT) in the diagnosis of intrapelvic masses (author's transl)]. Kuroda T Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Aug; 39(8):821-39. PubMed ID: 503803 [No Abstract] [Full Text] [Related]
17. [Fine-needle aspiration cytology in gynecology]. Gao QS Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):303-5, 319-20. PubMed ID: 4085299 [No Abstract] [Full Text] [Related]
18. Ultrasound characteristics of different types of adnexal malignancies. Valentin L; Ameye L; Testa A; Lécuru F; Bernard JP; Paladini D; Van Huffel S; Timmerman D Gynecol Oncol; 2006 Jul; 102(1):41-8. PubMed ID: 16386783 [TBL] [Abstract][Full Text] [Related]